ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CYTO Altamira Therapeutics Ltd

1.72
0.12 (7.50%)
After Hours
Last Updated: 16:25:04
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Altamira Therapeutics Ltd CYTO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.12 7.50% 1.72 16:25:04
Open Price Low Price High Price Close Price Prev Close
1.54 1.4952 1.77 1.72 1.60
more quote information »

Recent News

Date Time Source Heading
4/24/202408:47GLOBEAltamira Therapeutics Announces Publication of Positive..
4/10/202408:00GLOBEAltamira Therapeutics Provides Business Update, Reports Full..
4/04/202408:45GLOBEAltamira Therapeutics to Host Full Year 2023 Financial..
3/25/202408:47GLOBEAltamira Therapeutics Announces Collaboration with..
2/07/202408:47GLOBEAltamira Therapeutics’ Peptide-Based Delivery Platform Shown..
1/24/202408:47GLOBEAltamira Therapeutics Files Second Provisional Patent..
1/22/202417:02EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
1/22/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
1/19/202416:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/19/202416:40EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
1/19/202416:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/08/202417:02EDGAR2Form F-3 - Registration statement by foreign private issuers
1/08/202408:47GLOBEAltamira Therapeutics to Present at 3rd Annual mRNA-Based..
12/29/202308:47GLOBEAltamira Therapeutics Regains Compliance with Nasdaq Minimum..
12/11/202308:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/11/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/11/202308:00GLOBEAltamira Therapeutics Provides Investor and Business Update
12/08/202309:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/05/202312:54GLOBEAltamira Therapeutics to Host Investor & Business Update..
11/29/202310:20GLOBEAltamira Therapeutics Regains Compliance with Nasdaq Minimum..
11/22/202316:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/21/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/17/202309:04GLOBEAltamira Therapeutics Announces Partial Spin-Off of Bentrio®..
11/10/202308:47GLOBEAltamira Therapeutics Announces European Patent Office..
10/31/202316:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/04/202309:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/14/202308:47GLOBEAltamira Therapeutics Reports Additional Significant..
9/12/202307:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/12/202307:30GLOBEAltamira Therapeutics Provides Business Update and First..
9/06/202308:47GLOBEAltamira Therapeutics to Host First Half 2023 Financial..
8/23/202308:47GLOBEAltamira Therapeutics to Present at H.C. Wainwright 25th..
8/21/202307:31EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
7/28/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/26/202309:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/20/202308:47GLOBEAltamira Therapeutics and Pharma Nordic Collaborate for..
7/17/202308:47GLOBEAltamira Therapeutics Announces Publication of Positive..
7/11/202308:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/07/202316:14EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
7/05/202308:47GLOBEAltamira Therapeutics Announces Collaboration with Heqet..
6/30/202306:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Your Recent History

Delayed Upgrade Clock